Reckitt Benckiser Group’s (RB) Buy Rating Reaffirmed at Citigroup

Citigroup reissued their buy rating on shares of Reckitt Benckiser Group (LON:RB) in a research note issued to investors on Tuesday morning, Stock Target Advisor reports. Citigroup currently has a GBX 8,200 ($100.91) target price on the stock, up from their prior target price of GBX 7,200 ($88.60).

Several other equities research analysts have also issued reports on RB. Societe Generale decreased their price target on shares of Reckitt Benckiser Group from GBX 5,400 ($66.45) to GBX 5,200 ($63.99) and set a sell rating on the stock in a report on Thursday, June 4th. Barclays lifted their price target on shares of Reckitt Benckiser Group from GBX 7,900 ($97.22) to GBX 9,000 ($110.76) and gave the company an overweight rating in a report on Tuesday, June 23rd. Deutsche Bank lifted their price target on shares of Reckitt Benckiser Group from GBX 7,200 ($88.60) to GBX 7,400 ($91.07) and gave the company a buy rating in a report on Friday, May 1st. UBS Group raised shares of Reckitt Benckiser Group to a buy rating and lifted their price target for the company from GBX 5,700 ($70.15) to GBX 8,400 ($103.37) in a report on Monday. Finally, Credit Suisse Group lifted their price target on shares of Reckitt Benckiser Group from GBX 6,100 ($75.07) to GBX 6,850 ($84.30) and gave the company a neutral rating in a report on Friday, June 26th. Two research analysts have rated the stock with a sell rating, five have issued a hold rating and thirteen have assigned a buy rating to the company. The stock currently has an average rating of Buy and a consensus target price of GBX 7,117.37 ($87.59).

RB stock opened at GBX 7,432 ($91.46) on Tuesday. The company has a quick ratio of 0.40, a current ratio of 0.56 and a debt-to-equity ratio of 130.80. Reckitt Benckiser Group has a 12 month low of GBX 5,130 ($63.13) and a 12 month high of GBX 8,191.30 ($100.80). The firm has a market cap of $52.69 billion and a P/E ratio of -14.30. The company’s 50-day moving average price is GBX 7,055.16 and its two-hundred day moving average price is GBX 6,393.24.

In other news, insider Nicandro Durante purchased 165 shares of the company’s stock in a transaction dated Wednesday, May 27th. The shares were purchased at an average price of GBX 6,884 ($84.72) per share, for a total transaction of £11,358.60 ($13,978.10).

About Reckitt Benckiser Group

Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.

Further Reading: Understanding each part of a balance sheet

Analyst Recommendations for Reckitt Benckiser Group (LON:RB)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.